Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Genetic Technologies Inks US Commercialization Deal for COVID-19 Risk Test With Infinity Biologix

Genetic Technologies Inks US Commercialization Deal for COVID-19 Risk Test With Infinity Biologix

Mar 04, 2021
|
staff reporter

NEW YORK — Australian diagnostics firm Genetic Technologies said on Thursday that it has signed an agreement to commercialize its COVID-19 risk test in the US with Infinity Biologix.

Genetic Technologies' test is designed to assess the risk of an individual developing severe disease if they contract COVID-19 based on a combination of genetic and clinical factors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Mix of Human and Monkey

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

Fetal Tissue Policy Changes Expected

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

Science Papers on Approach to Isolate DNA from Sediment, Algorithm to Construct Signaling Networks

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Sequencing the Zoo

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

Apr
21
Featured Webinar

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

Sponsored by
Mission Bio

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies. 

Apr
22
Featured Webinar

Single-Cell Genomics Decodes the Developing Human Immune System

Sponsored by
10x Genomics

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

Apr
29
Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
12
Featured Webinar

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

Sponsored by
Combinati

This webinar will discuss a recent study that characterized the relationships between SARS-CoV-2 RNAemia and disease severity, clinical deterioration, and extrapulmonary complications (EPCs).

What's Popular?

In Molecular Diagnostics

  1. Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches

    Premium

  2. Columbia University-led Study Highlights Bionano Optical Genome Mapping Concordance with Cytogenetics

  3. Arcedi Biotech Introduces NIPT Analyzing DNA From Rare Fetal Cells in Maternal Blood

    Premium

  4. FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines

    Premium

  5. Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.